This site is intended only for US healthcare professionals.

IBTROZI™ (taletrectinib) logo
IBTROZI™ (taletrectinib) logo

What is ROS1+ NSCLC?

Efficacy

TKI-naïveTKI-pretreatedStudy design

Safety

Safety overviewLaboratory abnormalitiesDose modification ratesOnset and resolution

Dosing

Recommended dosingDose reductionsDrug interactionsDose modificationsMonitoring

Support and access

Patient support programDistribution information

Resources

HCP resourcesPatient and caregiver resources
HomeWhat is ROS1+ NSCLC?EfficacySafetyDosingSupport and accessResourcesContact a Rep

NSCLC=non-small cell lung cancer; ROS1=ROS proto-oncogene 1; TKI=tyrosine kinase inhibitor.